Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Expert Opin Biol Ther ; 12 Suppl 1: S99-111, 2012 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-22594608

RESUMO

INTRODUCTION: The content of GC-rich ribosomal repeats (rDNA) in cell-free DNA (cfDNA) of patients with various diseases is several times higher as compared with genomic DNA (gDNA) and cfDNA of healthy donors. rDNA may act as Toll-like receptor 9 (TLR9) ligands and affect human adipose-derived mesenchymal stem cells (haMSCs). Here we explore effects of human cfDNAs and model rDNA fragments on cultured haMSCs. AREAS COVERED: Both cfDNAs and cloned rDNA stimulate expression of TLR9 (qRT-PCR). Treatment with cloned rDNA leads to an increase in the number of TLR9(+) cells (FACS), expression levels for both TLR9 and Myd88, the translocation of nuclear factor-kappa B to the nuclei and up-regulation of TNFα and IL-10 cytokines (ELISA). As shown by an analysis of γH2AX-foci and MTT test, the preconditioning of haMSCs with cloned rDNA fragment increases the resistance of these cells to irradiation at 2Gy, while the treatments with control gDNA did not stimulate either TLR9- or NF-kB-dependent signaling pathways. EXPERT OPINION: GC-rich sequences present in cfDNA stimulate endogenous stems cells when body is exposed to adverse conditions. GC-rich fragments of human DNA may be used for preconditioning of therapeutic MSCs aiming at an increase in their survival in the ailing body.


Assuntos
Tecido Adiposo/metabolismo , DNA/fisiologia , Sequência Rica em GC , Células-Tronco Mesenquimais/metabolismo , NF-kappa B/metabolismo , Transdução de Sinais , Receptor Toll-Like 9/metabolismo , Tecido Adiposo/citologia , Células Cultivadas , DNA/química , Citometria de Fluxo , Humanos , Imuno-Histoquímica , Interleucina-10/metabolismo , Reação em Cadeia da Polimerase , Fator de Necrose Tumoral alfa/metabolismo , Regulação para Cima
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...